Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$4.08M Buy
78,459
+2,421
+3% +$131K 1.12% 27
2017
Q4
$4.08M Buy
76,038
+1,002
+1% +$55.5K 1.09% 28
2017
Q3
$4.58M Buy
75,036
+1,467
+2% +$88.9K 1.26% 20
2017
Q2
$4.5M Buy
73,569
+1,478
+2% +$90K 1.26% 18
2017
Q1
$4.37M Buy
72,091
+1,941
+3% +$118K 1.24% 20
2016
Q4
$3.94M Sell
70,150
-2,090
-3% -$122K 1.15% 23
2016
Q3
$4.3M Sell
72,240
-2,475
-3% -$145K 1.31% 19
2016
Q2
$4.11M Buy
74,715
+2,181
+3% +$116K 1.28% 18
2016
Q1
$3.66M Buy
72,534
+1,328
+2% +$65K 1.17% 23
2015
Q4
$3.59M Buy
71,206
+58,361
+454% +$2.94M 1.18% 23
2015
Q3
$605K Buy
12,845
+889
+7% +$47.2K 0.69% 37
2015
Q2
$649K Buy
11,956
+2,489
+26% +$140K 0.64% 35
2015
Q1
$519K Buy
9,467
+314
+3% +$17.8K 0.51% 41
2014
Q4
$496K Buy
+9,153
New +$510K 0.45% 42

Other funds holding MRK

Argent Trust's MRK Position: Q1 2018 in Review

Argent Trust increased its Merck (MRK) stake by 3.2% in Q1 2018, buying an estimated $131K and bringing the position to 78,459 shares worth $4.08M. The position accounts for 1.12% of the portfolio, ranked #27.

Argent Trust first reported a position in MRK in Q4 2014 and has held it in 14 quarters since. The position peaked at $4.58M in Q3 2017. 1,992 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

  • Argent Trust held 78,459 shares of Merck worth $4.08M as of Q1 2018.
  • Argent Trust bought 2,421 Merck shares in Q1 2018, an estimated $131K.
  • Merck made up 1.12% of Argent Trust's portfolio in Q1 2018, its #27 holding.
  • Argent Trust first reported a position in Merck in Q4 2014 and has held it in 14 quarters since.
  • Argent Trust's Merck position peaked at $4.58M in Q3 2017.
  • 1,992 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.